NRXS | tickerfilter.com

Fundamental analysis

34%

Profitability 35%

Dept financing 43%

Liquidity 33%

Performance 30%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

10.51%

1 Month

35.70%

3 Months

139.92%

6 Months

160.74%

1 Year

186.82%

2 Year

82.90%

Key data

Stock price

$6.31

P/E Ratio

0.00

DAY RANGE

$5.70 - $6.60

EPS

-$0.80

52 WEEK RANGE

$1.33 - $6.60

52 WEEK CHANGE

$192.13

MARKET CAP

30.365 M

YIELD

N/A

SHARES OUTSTANDING

10.653 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

0.20

PUBLIC FLOAT

AVERAGE 10 VOLUME

$106,140

AVERAGE 30 VOLUME

$120,604

Company detail

CEO: Brian Carrico
Region: US
Website: www.neuraxis.com
Employees: 0
IPO year: 2023

Issue type: Common Stock
Market: NYSE American
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

We are a growth stage company focused on developing neuromodulation therapies to address chronic and debilitating conditions in children. We incorporated in Indiana on April 17, 2012, under the name Innovative Health Solutions, Inc. On March 11, 2022, we amended our Articles of Incorporation to change our name to Neuraxis, Inc. On June 23, 2022, we changed our state of incorporation from Indiana to Delaware. Our principal executive offices are located at 11550 N. Meridian Street, Suite 325, Carmel, IN.

NRXS - Neuraxis, INC